文献速递免疫规划传染病防控与疫情报告

猪用疫苗佐剂的作用机制与佐剂效应综述

Adjuvants for swine vaccines: Mechanisms of actions and adjuvant effects.
PubMed 文献 · Vaccine · 2020-09-02

本文综述了猪用疫苗中多种佐剂的作用机制与佐剂效应,涵盖油乳剂、颗粒抗原载体、细胞因子、病原体相关分子模式与免疫配体、皂苷及细菌细胞与毒素等类型。佐剂机制分为递送载体与免疫刺激剂两类,其效果取决于疫苗抗原特性、佐剂机制、免疫应答类型及安全性等多种因素,成本效益亦受关注。

要点

  • 猪用疫苗佐剂按机制分为递送载体与免疫刺激剂两类。
  • 递送载体佐剂可形成储库、促进抗原递送至淋巴结并保护抗原。
  • 免疫刺激佐剂可招募活化抗原提呈细胞与T细胞并引导免疫类型。

核心结论

  • 猪用疫苗佐剂机制可分为递送载体与免疫刺激剂两类,其成功应用取决于疫苗抗原、佐剂机制、免疫应答类型及安全性等多因素。

研究设计与样本

  • 综述,汇总多种类型佐剂在猪疫苗中的测试情况,未报告检索范围与样本量。

主要发现

  • 已测试的猪用疫苗佐剂包括油乳剂、颗粒抗原载体、细胞因子、病原体相关分子模式与免疫配体、皂苷及细菌细胞与毒素。
  • 多种化学物质与天然产物在猪疫苗中显示佐剂活性,本文归为其他类。
  • 递送载体佐剂可形成储库、帮助抗原递送至引流淋巴结、促进抗原提呈细胞摄取并保护抗原。
  • 免疫刺激佐剂可招募活化抗原提呈细胞与T细胞、增强抗原提呈细胞功能并引导T细胞分化与免疫球蛋白同种型转换。

临床怎么用

  • 选择猪用疫苗佐剂时需综合考虑疫苗抗原类型与稳定性、接种剂量与程序、佐剂机制、免疫应答类型及安全性。
  • 佐剂应用还需关注成本效益,未来可探索能诱导黏膜免疫的候选佐剂。

局限性

  • 本文为综述,未报告原始研究的具体数值与样本量,结论基于所汇总文献。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This review deals with mechanisms of actions (MOA) and adjuvant effects of various types of adjuvants for swine vaccines. A number of different types of adjuvants have been tested with swine vaccines, including oil emulsion, particulate antigen (Ag) carrier, cytokines, pathogen-associated molecular patterns and immune ligands, saponins, and bacterial cells and toxins. In addition, there are a number of chemicals and natural products that possess adjuvant activities when tested with swine vaccines, and are grouped as miscellaneous in this review. The MOA of adjuvants can be generally divided into two categories: delivery vehicles and immunostimulants. Adjuvants serving as delivery vehicle can act as a depot, help deliver Ag to the draining lymph nodes, promote Ag uptake by antigen-presenting cells (APCs), and protect Ag from harsh conditions. Adjuvants possessing immunostimulatory activities may help recruit and activate APCs and T cells, enhance APC functions, and direct T cell differentiation and immunoglobulin isotype switching. Success of adjuvant use on improving immunogenicity and protective efficacy of swine vaccines depends on several factors, including type and stability of vaccine Ag, dose and schedule of vaccination, MOA of adjuvant, route, dose and schedule of adjuvant administration, type of immune response required, and safety from adverse reactions. In addition to the above mentioned factors, cost effectiveness is of concern. Further studies of swine vaccine adjuvants may need to focus on characterization of their MOA and search for more potential adjuvant candidates that can induce mucosal immune response.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Charerntantanakul W. Adjuvants for swine vaccines: Mechanisms of actions and adjuvant effects. Vaccine. 2020. PMID: 32888738. doi:10.1016/j.vaccine.2020.08.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。